The HIV Epidemic in the United States – Epidemiological Projections and Public Economic Impact of Achieving Zero Transmission Goals
This analysis demonstrates that the benefits of HIV policy are not limited to the healthcare setting and show how initial investments provide long-term benefits by preventing HIV transmission and the associated impact on individuals' labor market outcomes. While relying on assumptions and projections that may not capture all real-word complexities, fiscal analyses can provide a useful tool for policy evaluation that facilitate a holistic assessment of the wider costs and benefits that fall on governments as well as benefits of achieving policy targets.
Authors
- Maarten Jacobus Postma (ORCID: https://orcid.org/0000-0002-6306-3653)
- Rui Martins (ORCID: https://orcid.org/0000-0003-4200-3106)
- Ryan Thaliffdeen (ORCID: https://orcid.org/0009-0000-7231-1471)
- Cillian Copeland (ORCID: https://orcid.org/0009-0008-3923-5794)
- Nikolaos Kotsopoulos (ORCID: https://orcid.org/0000-0002-8248-7697)
- Paresh Chaudhari
- James Jarrett (ORCID: https://orcid.org/0000-0002-3570-8581)
- Uche Mordi
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Universitas Airlangga (ID)
- Gilead Sciences (United Kingdom) (GB)
- Gilead Sciences (United States) (US)
- Athens University of Economics and Business (GR)
- Padjadjaran University (ID)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/ceor.s565189
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences